[2012: news in neurology].
In 2012, intramuscular midazolam appears as effective as intravenous lorezepam for the first line treatment of convulsive status epilepticus. Perampanel, a new anti-epileptic drug, will be soon available. Two oral treatments are now available for stroke prevention in atrial fibrillation setting. The methylphenidate and the Tai Chi could increase the walk capacity of patients suffering from Parkinson disease. A comprehensive cardiac work-up is essential for some congenital myopathy. A new drug against migraine seems free from vasoconstrictive effect. Antioxidants are harmful in Alzheimer disease. Some oral medication will be available for multiple sclerosis.
Service de neurologie, Département des neurosciences cliniques, CHUV, Lausanne. vincent.alvarez@chuv.ch
V
V
Alvarez
A O
AO
Rossetti
P
P
Michel
T
T
Kuntzer
B
B
Nater
J-F
JF
Démonet
M
M
Schluep
R
R
Du Pasquier
F
F
Vingerhoets
D000927:Anticonvulsants / Q000627:therapeutic use; D002561:Cerebrovascular Disorders / Q000628:therapy; D003704:Dementia / Q000628:therapy; D020820:Dyskinesias / Q000628:therapy; D004827:Epilepsy / Q000188:drug therapy; D006801:Humans; D001523:Mental Disorders / Q000628:therapy; D015213:Neuroimmunomodulation / Q000502:physiology; D009462:Neurology / Q000379:methods / Q000639:trends*; D009468:Neuromuscular Diseases / Q000628:therapy; D035703:Therapies, Investigational / Q000379:methods / Q000639:trends
D000927:Anticonvulsants